This grant supports training and career development for clinician-scientists in cancer research, allowing participation in mentor-led clinical trials but not independent trials.
Funder: National Institutes of Health
Due Dates: February 12, 2027 (New) | March 12, 2027 (Renewal/resubmission/revision) | June 12, 2027 (New) | July 12, 2027 (Renewal/resubmission/revision) | February 12, 2028 (New) | March 12, 2028 (Renewal/resubmission/revision) | June 12, 2028 (New) | July 12, 2028 (Renewal/resubmission/revision) | February 12, 2029 (New) | March 12, 2029 (Renewal/resubmission/revision)
Funding Amounts: Up to 5 years; new programs: $50,000 direct costs in year 1, then $750,000 annually; renewals: $750,000 annually
Summary: Supports institutional career development programs that train clinician-scientists in clinical and translational cancer research.
Key Information: Scholars cannot lead independent clinical trials but may gain experience in mentor- or co-mentor-led trials.
The Paul Calabresi Career Development Award for Clinical Oncology supports institutional programs designed to increase the number of clinician-scientists trained in clinical and translational cancer research and advance their careers as cancer researchers. Administered by the National Cancer Institute (NCI), this K12 mechanism supports organizations providing biomedical research career development opportunities relevant to the National Cancer Program.
Programs must offer well-designed, rigorous career development activities, supported by appropriate faculty, staff, potential scholars, and on-site facilities. Career development components must be clearly distinct from other federally supported programs at the institution. Scholars may gain clinical trial research experience under a mentor or co-mentor, but may not propose to lead independent clinical trials.